AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 148 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | – | 316 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 316 | 0.0% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 316 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 316 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 316 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 316 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 316 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | -50.0% | 316 | -60.7% | 0.00% | – |
Q3 2020 | $2,000 | -66.7% | 805 | +8.8% | 0.00% | – |
Q2 2020 | $6,000 | 0.0% | 740 | 0.0% | 0.00% | – |
Q1 2020 | $6,000 | +20.0% | 740 | 0.0% | 0.00% | – |
Q4 2019 | $5,000 | +66.7% | 740 | 0.0% | 0.00% | – |
Q3 2019 | $3,000 | -25.0% | 740 | 0.0% | 0.00% | – |
Q2 2019 | $4,000 | -33.3% | 740 | 0.0% | 0.00% | – |
Q1 2019 | $6,000 | +500.0% | 740 | +183.5% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 261 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | -33.3% | 261 | 0.0% | 0.00% | – |
Q2 2018 | $3,000 | +50.0% | 261 | 0.0% | 0.00% | – |
Q1 2018 | $2,000 | – | 261 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $10,515,000 | 10.70% |
Orchard Capital Management, LLC | 1,593,531 | $3,601,000 | 1.06% |
Nantahala Capital Management | 4,918,565 | $11,116,000 | 0.39% |
Ardent Capital Management, Inc. | 168,811 | $382,000 | 0.25% |
Birchview Capital, LP | 100,000 | $226,000 | 0.15% |
Nantahala Capital Management | 1,000,000 | $2,260,000 | 0.08% |
PDT Partners, LLC | 433,400 | $979,000 | 0.08% |
Woodline Partners LP | 2,231,966 | $5,044,000 | 0.07% |
Virtus ETF Advisers LLC | 69,015 | $156,000 | 0.06% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 2,737,900 | $6,188,000 | 0.04% |